We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-2.75%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.1B
AUM Growth
+$273M
Cap. Flow
-$650M
Cap. Flow %
-4.61%
Top 10 Hldgs %
32.88%
Holding
703
New
–
Increased
221
Reduced
319
Closed
43

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$41.6M
2
NVDA icon
NVIDIA
NVDA
+$36M
3
ISRG icon
Intuitive Surgical
ISRG
+$33.8M
4
AMAT icon
Applied Materials
AMAT
+$32.4M
5
XP icon
XP
XP
+$31M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$57.8M
2
JNJ icon
Johnson & Johnson
JNJ
+$54.9M
3
DHR icon
Danaher
DHR
+$41.9M
4
MSFT icon
Microsoft
MSFT
+$40.7M
5
LRCX icon
Lam Research
LRCX
+$37.4M

Sector Composition

Rank Sector Weight
1 Healthcare 26.08%
2 Technology 25.64%
3 Financials 11.81%
4 Industrials 7.9%
5 Materials 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GIS icon
151
General Mills
GIS
$19.5B
$18.9M 0.13%
295,651
+7,477
+3% +$528K
PH icon
152
Parker-Hannifin
PH
$124B
$18.8M 0.13%
48,213
-24,913
-34% -$10M
XYL icon
153
Xylem
XYL
$28.6B
$18.2M 0.13%
201,013
+61,132
+44% +$6.31M
MMM icon
154
3M
MMM
$91.9B
$18.2M 0.13%
232,278
+188,118
+426% +$16.2M
CVS icon
155
CVS Health
CVS
$137B
$18.1M 0.13%
259,572
-47,200
-15% -$3.34M
DDOG icon
156
Datadog
DDOG
$89.7B
$18.1M 0.13%
198,461
-2,664
-1% -$264K
DD icon
157
DuPont de Nemours
DD
$18.9B
$17.9M 0.13%
191,386
+116,531
+156% +$10.9M
LW icon
158
Lamb Weston
LW
$7.3B
$17.8M 0.13%
192,835
+30,690
+19% +$3.11M
IMGN
159
DELISTED
Immunogen Inc
IMGN
$17.8M 0.13%
1,122,588
+130,006
+13% +$2.16M
EL icon
160
Estee Lauder
EL
$30.1B
$17.7M 0.13%
122,215
-77,298
-39% -$12.9M
ITT icon
161
ITT
ITT
$17.7B
$17.6M 0.13%
180,261
+89,264
+98% +$8.76M
SHW icon
162
Sherwin-Williams
SHW
$80.7B
$17.6M 0.13%
69,194
+51,659
+295% +$13.8M
CAT icon
163
Caterpillar
CAT
$402B
$17.6M 0.13%
64,605
-94,800
-59% -$25.7M
PLD icon
164
Prologis
PLD
$137B
$17.1M 0.12%
152,715
-406
-0.3% -$49.7K
PNC icon
165
PNC Financial Services
PNC
$99.6B
$16.7M 0.12%
136,865
+2,932
+2% +$369K
INTU icon
166
Intuit
INTU
$83.1B
$16.5M 0.12%
32,356
+1,260
+4% +$638K
GWW icon
167
W.W. Grainger
GWW
$66B
$16.5M 0.12%
23,807
-14,966
-39% -$10.8M
SRPT icon
168
Sarepta Therapeutics
SRPT
$1.68B
$16.5M 0.12%
135,709
+35,709
+36% +$4.04M
MCK icon
169
McKesson
MCK
$99.5B
$16.1M 0.11%
37,091
+30,269
+444% +$12.8M
MET icon
170
MetLife
MET
$61.2B
$16.1M 0.11%
256,014
+160,112
+167% +$9.97M
NUVL
171
DELISTED
Nuvalent
NUVL
$16.1M 0.11%
350,017
+70,001
+25% +$3.11M
RVMD icon
172
Revolution Medicines
RVMD
$40B
$15.6M 0.11%
561,948
-18,000
-3% -$534K
EXEL icon
173
Exelixis
EXEL
$14B
$15.5M 0.11%
711,625
-290,012
-29% -$6.07M
MDB icon
174
MongoDB
MDB
$24.9B
$15.5M 0.11%
44,926
-14,760
-25% -$5.6M
LEGN icon
175
Legend Biotech
LEGN
$3.73B
$15.5M 0.11%
231,032
– –
5 6
7
8 9

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2023 Portfolio in Review

As of Q3 2023, Candriam SCA held 703 positions worth $14.1B, up 2% from $13.8B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Candriam SCA withdrew a net $650M in Q3 2023, closing 43 positions and reducing 319 holdings. Its most notable exit was Chinook Therapeutics, Inc. Common Stock, an estimated $31.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 31% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA added an estimated $41.6M to Amgen.

  • Candriam SCA added most to Amgen in Q3 2023, an estimated $41.6M increase.
  • Candriam SCA's biggest Q3 2023 reduction was Visa, cutting an estimated $57.8M.
  • Candriam SCA fully exited Chinook Therapeutics, Inc. Common Stock in Q3 2023, selling an estimated $31.7M.
  • Candriam SCA's ten largest holdings make up 33% of its $14.1B portfolio in Q3 2023.
  • Candriam SCA opened 0 new positions and closed 43 in Q3 2023.
  • Candriam SCA's portfolio value rose 2% quarter-over-quarter to $14.1B.

Based on Candriam SCA's 13F filing for Q3 2023, filed 13 Nov 2023.